OmniAb
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5980 Horton St Ste 600, Emeryville, Cali...Phone Number
(510) 250-7800Website
www.omniab.comRevenue
$28.9 MillionStock Symbol
OABIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About OmniAb
OmniAb, founded in 2007, is a biotechnology research and development company that provides pharmaceutical industry partners with antibody discovery platforms. The company specializes in transgenic animal technologies including OmniRat, OmniChicken, OmniMouse, OmniFlic, OmniClic, and OmniTaur, which are genetically modified to generate antibodies with human sequences for therapeutic development. OmniAb combines these biological systems with computational antigen design, immunization methods, and high-throughput screening to identify antibodies for pharmaceutical applications. The company also offers OmniDeep, a suite of in silico tools for therapeutic discovery and optimization. OmniAb technologies support various antibody modalities including bispecific antibodies and antibody-drug conjugates, providing customizable solutions for pharmaceutical research and development needs.Explore more
OmniAb Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OmniAb your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once OmniAb has new funding data
Click to see if OmniAb had a recent Job posting/layoffs
Product Launch: Get notified when OmniAb launches new products
Check if OmniAb has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at OmniAb
Competitive Alert! Recent activity has been detected by your competitor Masked Content
OmniAb, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on OmniAb recently announced quarterly report
Check out if OmniAb is spiking on competitors!
Recommended Actions
Find VP level buyers at OmniAb
Find 3 more new buyers
Compare Similar Companies to OmniAb
Compare insights from companies similar to OmniAb, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
OmniAb is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
OmniAb is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about OmniAb.
OmniAb financials insights
Gather financial insights about OmniAb, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Private Equity
$30M
OmniAb Tech Stack
A closer look at the technologies used by OmniAb
See more technologies
Most Recent Scoops
Person-Based
Partnership, Clinical Operations
Person-Based
Executive Moves, Earnings, Finance
Person-Based
Events, Research & Development
Person-Based
Partnership, Earnings, Product Launch, Finance
Person-Based
Earnings, Finance
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding OmniAb
Sign Up For FreeTo access detailed company insights
OmniAb, founded in 2007, is a biotechnology research and development company that provides pharmaceutical industry partners with antibody discovery platforms. The company specializes in transgenic animal technologies including OmniRat, OmniChicken, OmniMouse, OmniFlic, OmniClic, and OmniTaur, which are genetically modified to generate antibodies wi... Read More
